Anupam Rama
Stock Analyst at J.P. Morgan
(4.84)
# 422
Out of 4,988 analysts
795
Total ratings
49%
Success rate
20.4%
Average return
Main Sectors:
Stocks Rated by Anupam Rama
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELC Celcuity | Initiated Coverage: Buy | $157 | $80.61 | +94.76% | 1 | Sep 17, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Hold | n/a | $20.11 | - | 65 | Sep 15, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | n/a | $34.00 | - | 35 | Sep 15, 2026 | |
| AGMB AgomAb Therapeutics NV | Reiterated: Buy | n/a | $12.17 | - | 2 | Sep 14, 2026 | |
| OLMA Olema Pharmaceuticals | Reiterated: Buy | n/a | $9.82 | - | 32 | Sep 14, 2026 | |
| COGT Cogent Biosciences | Reiterated: Buy | $62 | $31.50 | +96.83% | 17 | Sep 9, 2026 | |
| RARE Ultragenyx Pharmaceutical | Downgraded: Hold | $80 → $36 | $14.51 | +148.10% | 32 | Sep 3, 2026 | |
| ANNX Annexon | Rated: Buy | $14 | $4.23 | +230.97% | 21 | Sep 1, 2026 | |
| ERAS Erasca | Reiterated: Buy | $33 | $14.77 | +123.43% | 14 | Sep 1, 2026 | |
| KOD Kodiak Sciences | Reiterated: Buy | $66 → $69 | $32.71 | +110.94% | 23 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $25.70 | +40.08% | 23 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $21 | $13.07 | +60.67% | 35 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $51 → $46 | $16.64 | +176.44% | 2 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $65 | $38.60 | +68.39% | 4 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.76 | +298.55% | 14 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.91 | - | 6 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $100 → $111 | $66.61 | +66.64% | 43 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $8.91 | +23.46% | 17 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $40 | $17.62 | +127.01% | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $62 | $38.41 | +61.42% | 38 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $217 | $146.23 | +48.40% | 66 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $12.79 | +79.83% | 31 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $90 | $62.76 | +43.40% | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $72 → $107 | $77.24 | +38.53% | 25 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9 | $4.24 | +112.26% | 3 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $3.76 | - | 5 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $69 → $70 | $55.20 | +26.81% | 34 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $53 | $22.52 | +135.35% | 11 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $1.83 | - | 2 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $12.20 | +55.74% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $21.40 | +86.92% | 2 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $10.11 | -40.65% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.16 | n/a | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $204 → $170 | $239.56 | n/a | 14 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $3.20 | n/a | 11 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.365 | n/a | 11 | Nov 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $27 → $5 | $9.69 | n/a | 6 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $64 | $68.78 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $48 | $33.07 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $8 | $90.25 | n/a | 3 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $45 | $143.00 | n/a | 6 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.75 | n/a | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $13 | $17.02 | n/a | 7 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $46.65 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $30 → $37 | $10.60 | n/a | 6 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 | $0.000001 | n/a | 8 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $56 → $10 | $10.02 | n/a | 5 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $17.11 | n/a | 1 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $2.09 | n/a | 2 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $46.64 | n/a | 9 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $65.37 | n/a | 10 | Nov 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $135.89 | n/a | 1 | Sep 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $4.36 | n/a | 10 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $15.13 | n/a | 4 | Jun 15, 2016 |
Celcuity
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $157
Current: $80.61
Upside: +94.76%
Sarepta Therapeutics
Sep 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $20.11
Upside: -
Vera Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $34.00
Upside: -
AgomAb Therapeutics NV
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.17
Upside: -
Olema Pharmaceuticals
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.82
Upside: -
Cogent Biosciences
Sep 9, 2026
Reiterated: Buy
Price Target: $62
Current: $31.50
Upside: +96.83%
Ultragenyx Pharmaceutical
Sep 3, 2026
Downgraded: Hold
Price Target: $80 → $36
Current: $14.51
Upside: +148.10%
Annexon
Sep 1, 2026
Rated: Buy
Price Target: $14
Current: $4.23
Upside: +230.97%
Erasca
Sep 1, 2026
Reiterated: Buy
Price Target: $33
Current: $14.77
Upside: +123.43%
Kodiak Sciences
Sep 1, 2026
Reiterated: Buy
Price Target: $66 → $69
Current: $32.71
Upside: +110.94%
Sep 1, 2026
Reiterated: Buy
Price Target: $36
Current: $25.70
Upside: +40.08%
Aug 26, 2026
Rated: Buy
Price Target: $20 → $21
Current: $13.07
Upside: +60.67%
Aug 25, 2026
Rated: Buy
Price Target: $51 → $46
Current: $16.64
Upside: +176.44%
Aug 19, 2026
Reiterated: Buy
Price Target: $30 → $65
Current: $38.60
Upside: +68.39%
Aug 17, 2026
Reiterated: Buy
Price Target: $11
Current: $2.76
Upside: +298.55%
Aug 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.91
Upside: -
Aug 12, 2026
Rated: Buy
Price Target: $100 → $111
Current: $66.61
Upside: +66.64%
Aug 11, 2026
Reiterated: Buy
Price Target: $11
Current: $8.91
Upside: +23.46%
Aug 11, 2026
Reiterated: Buy
Price Target: $45 → $40
Current: $17.62
Upside: +127.01%
Aug 10, 2026
Reiterated: Buy
Price Target: $66 → $62
Current: $38.41
Upside: +61.42%
Aug 6, 2026
Reiterated: Buy
Price Target: $217
Current: $146.23
Upside: +48.40%
Aug 6, 2026
Reiterated: Buy
Price Target: $23
Current: $12.79
Upside: +79.83%
Aug 6, 2026
Reiterated: Buy
Price Target: $53 → $90
Current: $62.76
Upside: +43.40%
Jul 29, 2026
Rated: Buy
Price Target: $72 → $107
Current: $77.24
Upside: +38.53%
Jun 22, 2026
Upgraded: Buy
Price Target: $9
Current: $4.24
Upside: +112.26%
Jun 2, 2026
Downgraded: Sell
Price Target: n/a
Current: $3.76
Upside: -
May 22, 2026
Reiterated: Buy
Price Target: $69 → $70
Current: $55.20
Upside: +26.81%
May 22, 2026
Reiterated: Buy
Price Target: $58 → $53
Current: $22.52
Upside: +135.35%
Mar 24, 2026
Reiterated: Sell
Price Target: n/a
Current: $1.83
Upside: -
Mar 3, 2026
Reiterated: Buy
Price Target: $19
Current: $12.20
Upside: +55.74%
Dec 18, 2025
Reiterated: Buy
Price Target: $40
Current: $21.40
Upside: +86.92%
Nov 18, 2025
Reiterated: Sell
Price Target: $6
Current: $10.11
Upside: -40.65%
May 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $17.16
Upside: n/a
Feb 1, 2024
Reiterated: Hold
Price Target: $204 → $170
Current: $239.56
Upside: n/a
Dec 22, 2023
Downgraded: Sell
Price Target: n/a
Current: $3.20
Upside: n/a
Nov 13, 2022
Downgraded: Sell
Price Target: n/a
Current: $0.365
Upside: n/a
Aug 15, 2022
Reiterated: Hold
Price Target: $27 → $5
Current: $9.69
Upside: n/a
May 11, 2022
Reiterated: Buy
Price Target: $55 → $64
Current: $68.78
Upside: n/a
May 10, 2022
Reiterated: Hold
Price Target: $50 → $48
Current: $33.07
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $9 → $8
Current: $90.25
Upside: n/a
May 6, 2022
Reiterated: Buy
Price Target: $51 → $45
Current: $143.00
Upside: n/a
Mar 8, 2022
Downgraded: Hold
Price Target: n/a
Current: $4.75
Upside: n/a
Feb 25, 2022
Reiterated: Hold
Price Target: $12 → $13
Current: $17.02
Upside: n/a
Nov 12, 2021
Reiterated: Buy
Price Target: $55
Current: $46.65
Upside: n/a
Oct 25, 2021
Upgraded: Hold
Price Target: $30 → $37
Current: $10.60
Upside: n/a
Aug 5, 2021
Upgraded: Buy
Price Target: $6
Current: $0.000001
Upside: n/a
Mar 25, 2021
Downgraded: Sell
Price Target: $56 → $10
Current: $10.02
Upside: n/a
Oct 12, 2020
Initiated Coverage: Buy
Price Target: $27
Current: $17.11
Upside: n/a
Jun 5, 2019
Downgraded: Sell
Price Target: n/a
Current: $2.09
Upside: n/a
Mar 1, 2019
Reiterated: Buy
Price Target: $7 → $6
Current: $46.64
Upside: n/a
Nov 16, 2017
Upgraded: Hold
Price Target: n/a
Current: $65.37
Upside: n/a
Sep 29, 2017
Reiterated: Hold
Price Target: n/a
Current: $135.89
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $20 → $19
Current: $4.36
Upside: n/a
Jun 15, 2016
Reiterated: Hold
Price Target: n/a
Current: $15.13
Upside: n/a